Stefanie Loeser
About Stefanie Loeser
Stefanie Loeser is the Senior Medical Manager Oncology Pipeline & Upper GI at Bristol Myers Squibb in München, Bayern, Deutschland, with extensive experience in cancer biology and immunology research.
Current Role at Bristol Myers Squibb
Stephanie Loeser is currently serving as the Senior Medical Manager Oncology Pipeline & Upper GI at Bristol Myers Squibb in München, Bayern, Deutschland. In her role, she is responsible for overseeing medical strategies and initiatives related to the oncology pipeline with a specific focus on upper gastrointestinal cancers.
Career History in Oncology
Stephanie Loeser has an extensive career history in the field of oncology. From 2016 to 2021, she worked as a Disease Area Specialist Oncology at Bristol Myers Squibb in the Munich Area, Germany. Prior to that, she served as a Scientific Advisor Immuno-Oncology at the same company from 2014 to 2016. She also held the position of Medical Advisor Oncology at Novartis from 2013 to 2014 in Wien, and earlier, she was the Medical Information and Communication Manager Oncology/Haematology at Amgen GmbH from 2012 to 2013 in Austria.
Academic Background and Research Experience
Stephanie Loeser earned her PhD in Molecular Biology from Universität Wien, where she studied from 2003 to 2007. She also holds a Diploma in Biology from Ludwig-Maximilians-Universität München, completed between 1998 and 2003. Her research experiences include roles such as a Postdoc at Genentech (2008-2011) and a Research Fellow at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) from 2007 to 2008. In addition, she was a PhD student at IMBA from 2003 to 2007 and a Diploma student at the Max Planck Institute for Neurobiology from 2002 to 2003.
Professional Skills and Expertise
Stephanie Loeser is proficient in evaluating biologics and low molecular weight compounds in preclinical models of human cancer. She has over 10 years of experience in cancer biology and immunology research in both industry and academic settings. Her expertise includes the statistical and scientific evaluation of clinical data sets and the ability to communicate complex medical and scientific ideas fluently in both English and German.
Key Contributions and Activities
Stephanie Loeser played a vital role in leading the medical pre- and post-launch activities for the first PD-1 compound and the first Immuno-Oncology combination therapy in Austria, an early launch market. She is known for her strong analytic and organizational skills, ability to work independently, and adaptability to dynamic situations. Her international experience and capacity to work in cross-functional environments further enhance her contributions to the field.